The National Agency For Food And Drug Administration And Control, NAFDAC, has approved a herbal drug called GLUCOZIL for the treatment of diabetes mellitus.
The drug, GLUCOZIL, is produced by Edo Government-owned Ambrose Alli University Ekpoma.
The university’s head of corporate communication, office of the Vice Chancellor, Mike Aladenika, announced the news in a statement made available to the News Agency of Nigeria (NAN) in Benin on Thursday.
“Its bid to reclaim its enviable position among the comity of institutions, grounded in research and higher learning, has received the approval of NAFDAC, as well as the rights of production and patents of GLUCOZIL.”
Dr Jonathan Emeka Emordi, Head, Department of Pharmacology, and Sub-Dean, Basic Clinical Sciences, College of Medicine, AAU, who developed GLUCOZIL, explained that the drug is a natural product intended to treat diabetes by regenerating damaged beta cells.
Dr. Emordi claims that GLUCOZIL not only manages diabetes but can even cure it completely with prolonged use.
He also highlighted that GLUCOZIL isn’t just for managing diabetes – it can also treat an enlarged prostate (BPH).
He emphasized that GLUCOZIL is a versatile drug that can tackle multiple health issues, and it’s an effective and safe alternative to conventional medications for these conditions.
“In my analysis of the product, it was discovered that it has the capacity to shrink the prostate so that surgical operations can be avoided.
“The product is scientifically tested, right dose confirmed, safety proven in both humans and animals.
“It is also capable of flushing the human system. Simply put, it is a detoxifier. It has strong anti-oxidant and anti-inflammatory activities which makes it an immune booster.”
Commending Emordi, AAU acting VC, Prof. Sonnie Adagbonyin, said the management was happy with the feat achieved at the College of Medicine and the Department of Pharmacology.
“We are proud of the ranking of our scholars who are determined to excel, do us proud despite the various human and environmental challenges.
“The Management is proud of Dr. Emordi and I enjoin other scholars to see his achievement as motivation for them to break new grounds, open new frontiers of knowledge and innovation for the further progress of this university.”
